GAMMA Investing’s Maze Therapeutics MAZE Stock Holding History

GAMMA Investing’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.07K	Sell	170 -182	-52%	-$4.77K	﹤0.01%	3464
2026 Q1	$10.5K	Buy	352 +180	+105%	+$7.94K	﹤0.01%	3051
2025 Q4	$7.13K	Buy	172 +13	+8%	+$447	﹤0.01%	3128
2025 Q3	$4.12K	Buy	159 +108	+212%	+$1.82K	﹤0.01%	3248
2025 Q2	$626	Buy	+51	New	+$531	﹤0.01%	3610

Other funds holding MAZE

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FWP

Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

GAMMA Investing's MAZE Position: Q2 2026 in Review

GAMMA Investing reduced its Maze Therapeutics (MAZE) stake by 52% in Q2 2026, selling an estimated $4.77K and leaving 170 shares worth $5.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3464.

GAMMA Investing first reported a position in MAZE in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.5K in Q1 2026. 7 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

GAMMA Investing held 170 shares of Maze Therapeutics worth $5.07K as of Q2 2026.
GAMMA Investing sold 182 Maze Therapeutics shares in Q2 2026, an estimated $4.77K.
Maze Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3464 holding.
GAMMA Investing first reported a position in Maze Therapeutics in Q2 2025 and has held it in 5 quarters since.
GAMMA Investing's Maze Therapeutics position peaked at $10.5K in Q1 2026.
7 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.